Objectives: Factors related to readmission after pancreaticoduodenectomy (PD) may include postoperative morbidity and the functional status of the patient. This study aimed to retrospectively review our institution's experience of readmission of patients who had undergone Whipple procedure PD.

Methods: Recidivism was defined as readmission to the primary or a secondary hospital within, respectively, 30 days, 30-90 days or 90 days postoperatively. Associations between recidivism, perioperative factors and patient characteristics were evaluated.

Results: During the past 5 years, 30-day, 30-90-day and 90-day recidivism rates were 14.5%, 18.5% and 27.4%, respectively. The most common reasons for readmission included dehydration and/or malnutrition (37.5% of readmissions) and pain (12.5%). Patients who underwent PD for chronic pancreatitis were more likely to be readmitted within 90 days of surgery than patients who underwent PD for malignancy (P < 0.01). Intraoperative transfusion was also associated with 30-90-day and 90-day recidivism (P < 0.01). Preoperative comorbidities, including Charlson Comorbidity Index score, number of pre-discharge complications, type of Whipple reconstruction, preoperative biliary stenting, need for vascular reconstruction and patient body mass index were not associated with recidivism.

Conclusions: Our data confirm previous reports indicating high rates of readmission after PD. To our knowledge, this report is the first to demonstrate chronic pancreatitis as an independent risk factor for readmission.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244626PMC
http://dx.doi.org/10.1111/j.1477-2574.2011.00377.xDOI Listing

Publication Analysis

Top Keywords

30-90-day 90-day
8
90-day recidivism
8
patients underwent
8
chronic pancreatitis
8
readmission
6
recidivism
5
factors associated
4
associated recidivism
4
recidivism pancreaticoduodenectomy
4
pancreaticoduodenectomy objectives
4

Similar Publications

Background: The role of combination therapies for serious methicillin-resistant Staphylococcus aureus (MRSA) infections is widely debated.

Methods: This retrospective cohort study included adults with MRSA bacteraemia treated between January 1, 2013, to December 31, 2022. Patients receiving combination therapy with vancomycin and ceftaroline were matched in a 2:1 ratio with those on vancomycin monotherapy based on bacteraemia source and illness severity.

View Article and Find Full Text PDF

Purpose: To evaluate the clinical outcomes and safety of tigecycline (TGC) plus cefoperazone/sulbactam (CPS) or TGC monotherapy in patients with hospital-acquired pneumonia (HAP) caused by Carbapenem-Resistant (CRAB).

Methods: This was a retrospective analysis of multicenter data from 62 Chinese hospitals with CRAB HAP. Risk factors for receiving TGC with CPS therapy and predictors of mortality were assessed using multivariate logistic and Cox regression analyses, respectively.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed 998 patients who underwent percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) from 2007 to 2022, focusing on mortality predictors and trends.
  • Key findings showed that older age and conditions like myocardial infarction, diabetes, and chronic obstructive pulmonary disease worsened prognosis, while higher ejection fraction and use of intravascular imaging led to better outcomes.
  • Overall, the rate of LMCA PCI increased over the years, short-term mortality improved, but longer-term prognosis showed a trend toward worsening, highlighting the need to address multimorbidity in patients.
View Article and Find Full Text PDF

Purpose: Improved outcomes have been noted in patients undergoing malignant brain tumor resection at high-volume centers. Studies have arbitrarily chosen high-volume dichotomous cutoffs and have not evaluated volume-outcome associations at specific institutional procedural volumes. We sought to establish the continuous association of volume with patient outcomes and identify cutoffs significantly associated with mortality, major complications, and readmissions.

View Article and Find Full Text PDF

Background And Objectives: Primary adrenal sarcoma (PAS) is an exceedingly rare malignancy with limited data available on its epidemiology, management, and outcomes. This study aimed to characterize the national incidence, treatment patterns, and survival of PAS utilizing a National Cancer Database.

Methods: The National Cancer Database was queried for patients diagnosed with primary adrenal tumors from 2004 to 2019.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!